Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters











Database
Language
Publication year range
2.
Ter Arkh ; 68(12): 36-9, 1996.
Article in Russian | MEDLINE | ID: mdl-9054035

ABSTRACT

The cephalosporin antibiotic zinnat was given to 171 outpatients with bronchopulmonary infections. Pneumonia patients received 500 mg, patients with acute bronchitis or exacerbation of chronic bronchitis 250 mg twice a day. The recovery was registered in 97.7, 98.8 and 91.8% of patients, respectively. The drug proved effective, low-toxic, convenient in use. Wide-spectrum action, significant activity against both gram-positive and gram-negative pathogens make zinnat a promising drug for outpatient treatment of bronchopulmonary infections.


Subject(s)
Ambulatory Care , Bronchitis/drug therapy , Cefuroxime/analogs & derivatives , Cephalosporins/therapeutic use , Pneumonia, Bacterial/drug therapy , Prodrugs/therapeutic use , Acute Disease , Adolescent , Adult , Bronchitis/diagnosis , Cefuroxime/adverse effects , Cefuroxime/therapeutic use , Cephalosporins/adverse effects , Chronic Disease , Female , Humans , Male , Middle Aged , Pneumonia, Bacterial/diagnosis , Prodrugs/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL